North East and North Cumbria
ICS Formulary
ICS Formulary
6 Endocrine system
06-05-02 Antidiuretic hormone antagonists
| Demeclocycline |
|
Formulary
|
|
|
Links
MHRA Drug Safety Update (March 2023): Terlipressin: new recommendations to reduce risks of respiratory failure and septic shock in patients with type 1 hepatorenal syndrome- NICE TA358: Autosomal dominant polycystic kidney disease - tolvaptan
- NICE TA358: Autosomal dominant polycystic kidney disease - tolvaptan
- NTAG Endocrine System Recommendations